rs1781735
Orientation | minus |
Stabilized | minus |
Make rs1781735(A;A) |
Make rs1781735(A;C) |
Make rs1781735(C;C) |
Reference | GRCh38.p2 38.2/147 |
Chromosome | 6 |
Position | 38704303 |
Gene | GLO1 |
is a | snp |
is | mentioned by |
dbSNP | rs1781735 |
dbSNP (classic) | rs1781735 |
ClinGen | rs1781735 |
ebi | rs1781735 |
HLI | rs1781735 |
Exac | rs1781735 |
Gnomad | rs1781735 |
Varsome | rs1781735 |
LitVar | rs1781735 |
Map | rs1781735 |
PheGenI | rs1781735 |
Biobank | rs1781735 |
1000 genomes | rs1781735 |
hgdp | rs1781735 |
ensembl | rs1781735 |
geneview | rs1781735 |
scholar | rs1781735 |
rs1781735 | |
pharmgkb | rs1781735 |
gwascentral | rs1781735 |
openSNP | rs1781735 |
23andMe | rs1781735 |
SNPshot | rs1781735 |
SNPdbe | rs1781735 |
MSV3d | rs1781735 |
GWAS Ctlg | rs1781735 |
Max Magnitude | 0 |
? | (A;A) (A;C) (C;C) | 28 |
---|---|---|
|
[PMID 27000251] Role of glyoxalase I gene polymorphisms in late-onset epilepsy and drug-resistant epilepsy rs1781735 is a perfect proxy for rs1049346 with the G allele of rs1781735 corresponding to the C allele of rs1049346.The CC genotype of rs1049346 protects against late-onset epilepsy and drug resistant epilepsy (combined cohort, TT+TC/CC 2.645 p=0.000, and 3.049, p=0.001, respectively).
The presence of the TAC/AAT haplotypes (rs1130534-rs4746-rs1049346) may be used as a marker of predisposition to/protection against drug resistant epilepsy (combined cohorts, p=0.010 and 0.000 respectively. ORs are not provided ).